GSS.AX ASX
Genetic Signatures Limited
1W: +1.3%
1M: -9.2%
3M: +25.4%
YTD: -43.6%
1Y: -72.8%
3Y: -84.7%
5Y: -94.8%
A$0.08 ($0.05)
+0.00 (+0.00%)
Weekly Expected Move ±11.7%
A$0
A$0
A$0
A$0
A$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
-$8M
+36.8% ▲
Capital Expenditures
$1M
-16.2% ▼
5Y CAGR: -26.8%
Free Cash Flow
-$9M
+33.2% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+100.0% ▲
Net Change in Cash
$2M
+105.5% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $3M | -$14M | -$18M | $0 | -$14M |
| Depreciation & Amort. | $2M | $2M | $2M | $0 | $2M |
| Stock-Based Comp. | $2M | $2M | $0 | $0 | $0 |
| Change in Working Capital | $4M | -$2M | $4M | -$3M | $2M |
| Other Non-Cash Items | $1M | $8M | $2M | -$10M | $2M |
| Operating Cash Flow | $10M | -$12M | -$10M | -$12M | -$8M |
| — Investing Activities — | |||||
| Capital Expenditures | -$3M | -$8M | -$2M | -$653K | -$1M |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | -$23M | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $11M |
| Other Investing | -$1M | -$6M | -$3M | -$249K | $0 |
| Investing Cash Flow | -$3M | -$8M | -$5M | -$24M | $10M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $0 |
| Stock Repurchased | -$9K | -$1K | -$3M | -$554K | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$365K | -$33K | -$177K | -$430K | -$481K |
| Financing Cash Flow | -$101K | -$23K | $35M | $8M | -$481K |
| Net Change in Cash | $7M | -$21M | $20M | -$29M | $2M |
| Cash End of Period | $37M | $16M | $36M | $7M | $9M |
| Free Cash Flow | $7M | -$21M | -$15M | -$13M | -$9M |